COVID-19: Clinical trial of plasma therapy to begin in Kolkata - (Business Standard via NewsPoints Desk)

  • The West Bengal government in partnership with the Council of Scientific and Industrial Research (CSIR) is set to start clinical studies of convalescent plasma therapy in patients with COVID-19, as reported in Business Standard.

  • The purpose of the clinical trials, which recently gained approval from the Drug Control General of India, is to understand the efficacy of blood plasma of a recovered COVID-19 patient in the treatment of others suffering from the disease.

To read more NewsPoints articles, click here.